Literature DB >> 14571563

Sexual transmission of hepatitis C and early intervention.

Shona Fletcher1.   

Abstract

The major risk factors for the transmission of hepatitis C virus (HCV) have been sharing needles for intravenous drug use (IDU) and receiving blood and blood products; however, recent findings suggest that HCV is being increasingly sexually transmitted, particularly among HIV-positive men who engage in high-risk, unprotected sexual behaviors with other men. Sixteen HIV-positive patients were diagnosed with sexually acquired HCV infection at a leading London HIV outpatient treatment center during 2002. All 16 patients were homosexual males with no history of IDU who had been involved in high-risk, unprotected sexual behaviors, which included active and passive anal intercourse, fisting, rimming, and oral sex. Six patients (37.5%) in the cohort spontaneously cleared HCV infection and consequently tested negative for HCV RNA. The remaining 10 patients were all started on HCV treatment, which consisted of pegylated interferon alpha-2b in combination with ribavirin. Three patients (43%) have achieved a significant reduction in HCV RNA after 12 to 24 weeks of HCV treatment. The earlier HCV seroconversion is detected and treated, the better the chance of achieving viral eradication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571563     DOI: 10.1177/1055329003255815

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  10 in total

1.  Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.

Authors:  Lynn E Taylor; Marisa Holubar; Kunling Wu; Ronald J Bosch; David L Wyles; John A Davis; Kenneth H Mayer; Kenneth E Sherman; Karen T Tashima
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

2.  Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.

Authors:  Marek J Nowicki; Tomasz Laskus; Georgia Nikolopoulou; Marek Radkowski; Jeffrey Wilkinson; Wenbo B Du; Jorge Rakela; Andrea Kovacs
Journal:  J Infect Dis       Date:  2005-09-29       Impact factor: 5.226

Review 3.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

4.  Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk.

Authors:  L E Taylor; A K DeLong; M A Maynard; S Chapman; P Gholam; J T Blackard; J Rich; K H Mayer
Journal:  AIDS Patient Care STDS       Date:  2011-08-22       Impact factor: 5.078

Review 5.  Acute hepatitis C in an HIV-infected patient: a case report and review of literature.

Authors:  Todd H Driver; Norah Terrault; Varun Saxena
Journal:  J Gen Intern Med       Date:  2012-11-14       Impact factor: 5.128

6.  HCV enters the twenty-first century.

Authors:  Indira Brar; Dwayne Baxa; Norman Markowitz
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

7.  Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China.

Authors:  Yu-Hua Ruan; Kun-Xue Hong; Shi-Zhu Liu; Yi-Xin He; Feng Zhou; Guan-Ming Qin; Kang-Lin Chen; Hui Xing; Jian-Ping Chen; Yi-Ming Shao
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

8.  Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors.

Authors:  Hsin-Yun Sun; Sui-Yuan Chang; Zong-Yu Yang; Ching-Lan Lu; Hsiu Wu; Chang-Ching Yeh; Wen-Chun Liu; Chia-Yin Hsieh; Chien-Ching Hung; Shan-Chwen Chang
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

Review 9.  Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.

Authors:  Daniel J Smith; Ashly E Jordan; Mayu Frank; Holly Hagan
Journal:  BMC Infect Dis       Date:  2016-09-05       Impact factor: 3.090

Review 10.  Evolution of virulence.

Authors:  Paul W Ewald
Journal:  Infect Dis Clin North Am       Date:  2004-03       Impact factor: 5.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.